admin

The coronavirus pandemic has forced millions of Americans to work from home over the past month, and likely into the foreseeable future.   Understandably, working remotely is easier for some employees than others, as coordinating with colleagues sprawled across the map can prove to be a difficult test of patience and technology. But what do you
0 Comments
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs Revolutions, conflicts and surprise election results all constitute political risk. Companies need to tackle these to take advantage of areas with high potential returns. Michael Skapinker investigates for FT Special Reports series on corporate longevity. For more video content from the Financial Times, visit http://www.FT.com/video Twitter
0 Comments
filadendron As small businesses sought emergency federal loans, financial advisors not only assisted clients, but also applied for aid to bolster their practices. The Paycheck Protection Program, the $349 billion small-business loan offering, ran out of money on April 16 after being open for close to two weeks. More than 1.6 million businesses were approved
0 Comments
Secretary of the Treasury Steven Mnuchin speaks with President Donald J. Trump and members of the coronavirus task force during a briefing in response to the COVID-19 coronavirus pandemic on Thursday, April 02, 2020 in Washington, DC. (Photo by Jabin Botsford/The Washington Post via Getty Images) The Washington Post Veterans and their family members will
0 Comments
The historic $2.2 trillion stimulus package dramatically expanded unemployment insurance benefits for the millions of workers losing jobs and wages during the coronavirus pandemic. But while the relief bill was signed into law on March 27, it’s taken weeks for the U.S. Department of Labor to roll out guidelines to states, which administer unemployment programs, on how
0 Comments
Charlie Munger Lacy O’Toole | CNBC Speculation about what Berkshire Hathaway‘s Warren Buffett is doing during this crisis is a common topic among investors these days, with most expecting the “Oracle of Omaha” to make a classic value purchase during this tumultuous time or a rescue cash infusion to a struggling company he likes over the
0 Comments
A wave of new high-rise offices is cropping up in a section of London known for two things: the insurance industry and skyscrapers. The FT reports on whether there is enough demand from insurers to fill them or if London’s new skyscrapers will be empty ► Subscribe to FT.com here: http://on.ft.com/2eZZoLI ► Subscribe to the
0 Comments
June 13 (Bloomberg) — Behind two sets of ornate doors at Tiffany’s New York flagship store is a top-secret room. The Salon houses Tiffany’s most over-the-top pieces. The way you gain access is by referral or spending a lot of cash. With wedding season in full swing, Jeff Bennett, Tiffany’s vice president for the New
0 Comments
The seal of the Internal Revenue Service (IRS) hangs on a podium during an IRS Criminal Investigation 100th year anniversary event at the agency’s headquarters in Washington, D.C., U.S., on Monday, July 1, 2019. Photographer: Andrew Harrer/Bloomberg via Getty Images Bloomberg An unlikely group counts itself among the recipients of the coronavirus stimulus checks: the
0 Comments
Procter & Gamble on Friday reported that its fiscal third-quarter U.S. sales surged 10% as consumers stocked up on staples like Charmin toilet paper and Bounty paper towels ahead of the coronavirus outbreak. But the consumer products giant cut its revenue forecast for fiscal 2020, citing headwinds from foreign currency. Shares of the company rose less
0 Comments
A box containing a 5-minute test for COVID-19 from Abbott Laboratories is pictured during the daily briefing on the novel coronavirus, COVID-19, in the Rose Garden of the White House in Washington, DC, on March 30, 2020. Mandel Ngan | AFP | Getty Images Abbott Laboratories says it is ramping up production of its coronavirus test
0 Comments
A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters Gilead Sciences shares surged by more than 15% in after-hours trading Thursday after details leaked of a closely watched clinical trial of the company’s antiviral drug Remdesivir appeared to show promising results in treating Covid-19. The University
0 Comments